Author response to Letter to the Editor: "Statins and non-alcoholic fatty liver disease"

Liver Int. 2019 Sep;39(9):1788-1789. doi: 10.1111/liv.14191. Epub 2019 Jul 24.

Authors

Eline H van den Berg^{1

2}, Vincent E de Meijer³, Hans Blokzijl¹

Affiliations

¹ Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
² Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
³ Department of Hepatopancreatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

PMID: 31310401
DOI: 10.1111/liv.14191

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiovascular Diseases*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Non-alcoholic Fatty Liver Disease*
Risk Factors

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors